Differences in Anti-inflammatory Effects of Celecoxib Emulgel Preparations with Variations in Surfactant Concentration between Lecithin and Tween 80
DOI:
https://doi.org/10.35799/jis.v24i2.55977Keywords:
Anti-inflammatory, celecoxib, emulgel, surfactantAbstract
Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) which is widely used to treat inflammation such as rheumatoid arthritis and primary dysmenorrhea. The absorption of celecoxib in the body is very low when taken orally, so it can be increased by changing the route of administration via transdermal route such as emulgel. This study aims to determine the increase in the anti-inflammatory activity of celecoxib emulgel with varying concentrations of surfactants in formula with Lecithin and formula with Tween 80. Celecoxib emulgel, was made into 3 formulas with variations in the concentration for each formula with Lecithin (FI=3%; FII=5%; FIII=7%) and Tween 80 (FI=5%; FII=10%; FIII=15%). The anti-inflammatory activity test was carried out by inducing edema in the soles of rats' feet using carrageenan. Rats were divided into 5 groups for each formula: 1) negative control, 2) without surfactant, 3) FI, 4) FII, and 5) FIII. The edema volume was measured every 1 hour for 6 hours using a plethysmometer. Results of the anti-inflammatory test showed that the average value of AUC0-360 in the Lecithin group = 57.97-77.17 μg/hour/mL and in the Tween 80 group = 51.45-77.17 μg/hour/mL. %DAI results of formula without surfactant=9.33%, FI (Lecithin=10.01%; Tween 80=24.49%), FII (Lecithin=18.36%; Tween 80=29.05%), and FIII (Lecithin=24.88%; Tween 80=33.33%). Based on these data, it can be concluded that there is an increase in the anti-inflammatory effect of celecoxib emulgel with increasing surfactant concentration in the formula with Lecithin and in the formula with Tween 80.
Keywords: Anti-inflammatory; celecoxib; emulgel; surfactant
References
Dara, A. I., & Husni, P. (2017). Teknik Meningkatkan Kelarutan Obat. Farmaka, 15(4), 49–57.
Dewi, Y.N., Mulyanti, D., & Maulana, I.T. (2015). Optimasi Formulasi Basis Sediaan Emulgel dengan Variasi Konsentrasi Surfaktan. Prosiding Penelitian Sivitas Akademika Unisba, 287–291.
Dhawas, V., Dhabarde, D., & Patil, S. (2020). Emulgel: A Comprehensive Review For Novel Topical Drug Delivery System. International Journal of Recent Scientific Research, 11(4), 381343–38138. https://doi.org/10.24327/IJRSR.2020.1104.5247.
Ikhtiyarini, T.A., & Sari, A.K. (2022). Efektivitas Penggunaan Basis Gel pada Sediaan Emulgel Effectiveness of Basic Use for Emulgel Preparations. Journal Clinical, Pharmaceutical, Analitical, and Pharmacy Community, 1(1), 19–25.
Imananta, F.P., & Sulistiyaningsih. (2018). Artikel Tinjauan: Penggunaan NSAIDs (Non Steroidal Anti Inflamation Drugs) Menginduksi Peningkatan Tekanan Darah pada Pasien Arthritis. Farmaka, 16(1), 72–79.
Karade, P.G., Shah, R.R., Chougule, D.D., & Bhise, S.B. (2012). Formulation and Evaluation of Celecoxib Gel. Journal of Drug Delivery & Therapeutics, 2(3), 132–135. https://doi.org/10.22270/jddt.v2i3.148.
Kusmita, L., Setyani, W., & Puspitaningrum, I. (2015). Uji Efek Antiinflamasi Fraksi Etil Asetat Ekstrak Alfafa (Medicago sativa) pada Tikus Putih Jantan yang Diinduksi Karagenin. Jurnal Ilmu Farmasi Dan Farmasi Klinik, 47–54. https://doi.org/http://dx.doi.org/10.31942/jiffk.v0i0.1200.
Meghna, K.S., Salini, C., Sadiya, P., Srethuu, K.S., & Thushara, C. (2017). Formulation and Evaluation of Celecoxib Emulgel for Topical Delivery. American Journal of Biological and Pharmaceutical Research, 4(2), 54–59.
Patil, K.R., Mahajan, U.B., Unger, B.S., Goyal, S.N., Belemkar, S., Surana, S.J., Ojha, S., & Patil, C.R. (2019). Animal models of inflammation for screening of anti-inflammatory drugs: Implications for the discovery and development of phytopharmaceuticals. International Journal of Molecular Sciences, 20(18). https://doi.org/10.3390/ijms20184367.
Pratama, A.D., Wibisono, N., & Widyaningrum, I. (2024). Efek Variasi Surfaktan Kationik dan Nonionik dalam Emulgel Asam Mefenamat terhadap Aktivitas Antiinflamasi. Jurnal Biokomplementer Medicine, 11(1), 1–9.
Reddy, M.S., Tanzeem, S.K., & Haq, S.M.F. (2020). Formulation and Evaluation of Celecoxib Emulgel. International Journal of Pharmacy and Biological Sciences-IJPBS TM, 10(1), 10. www.ijpbs.comorwww.ijpbsonline.com80.
Rowe, R.C., Sheskey, P. J., & Quinn, M.E. (2009). Handbook of Pharmaceutical Excipients. In Pharmaceutical Press American Pharmacists Association (6th ed.). Pharmaceutical Press.
Rusli, N., Setiawan, M.A., & Hikmawati, N. (2021). Pengaruh HPMC Sebagai Basis Gel Serta Tween 80 Kombinasi Span 80 Sebagai Emulgator dalam Sediaan Emulgel Transdermal Asetosal. Jurnal Farmasi Sains Dan Praktis, 7(3), 249–259. https://doi.org/10.31603/pharmacy.v7i3.6093.
Sari, R., Nurbaeti, S.N., & Pratiwi, L. (2016). Optimasi Kombinasi Karbopol 940 dan HPMC Terhadap Sifat Fisik Gel Ekstrak dan Fraksi Metanol Daun Kesum (Polygonum minus Huds.) dengan metode Simplex Lattice Design. Pharmaceutical Sciences and Research, 3(2), 72–79. https://doi.org/10.7454/psr.v3i2.3288.
Shaker, D.S., Ishak, R.A.H., Ghoneim, A., & Elhuoni, M.A. (2019). Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Scientia Pharmaceutica, 87(3). https://doi.org/10.3390/scipharm87030017.
Singh, Y., Meher, J.G., Raval, K., Khan, F.A., Chaurasia, M., Jain, N.K., & Chourasia, M. K. (2017). Nanoemulsion: Concepts, Development and Applications in Drug Delivery. Journal of Controlled Release, 252, 28–49. DOI: 10.1016/j.jconrel.2017.03.008.
Soleha, M., Isnawati, A., Fitri, N., Adelina, R., Soblia, H. T., & Winarsih, W. (2018). Profil Penggunaan Obat Antiinflamasi Nonsteroid di Indonesia. Jurnal Kefarmasian Indonesia, October 2018, 109–117. https://doi.org/10.22435/jki.v8i2.316.
Soliman, S. M., Abdel Malak, N. S., El-Gazayerly, O. N., & Abdel Rehim, A. A. (2010). Formulation of Microemulsion Gel Systems for Transdermal Delivery of Celecoxib: In vitro Permeation, Anti-inflammatory Activity and Skin Irritation Tests. Drug Discoveries & Therapeutics, 4(6), 459–471.
Teaima, M. H., Badawi, N. M., Attia, D. A., El-Nabarawi, M. A., Elmazar, M. M., & Mousa, S. A. (2022). Efficacy of Pomegranate Extract Loaded Solid Lipid Nanoparticles Transdermal Emulgel Against Ehrlich ascites carcinoma. Nanomedicine: Nanotechnology, Biology and Medicine, 39, 102466. https://doi.org/10.1016/J.NANO.2021.102466.
Vanpariya, F., Shiroya, M., & Malaviya, M. (2021). Emulgel : A Review. International Journal of Science and Research, 10(3), 847–852. DOI:10.21275/SR21311095015.
Wibowo, D.N., Prihantini, M., Aini, R., & Yudianti, H.S. (2024). Formulation and Evaluation of Celecoxib Emulgel with Tween 80 And Lecitin For Transdermal Drug Delivery Formulasi dan Evaluasi emulgel Celecoxib dengan Tween 80 dan Lesitin untuk penghantaran obat transdermal. Indonesian Journal of Pharmaceutical Science and Technology, 11(2), 243–252.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Achmad Quraisy Aljufri, Muhammad Ikhsan, Danang Novianto Wibowo, Afif Rahmatun Hikmah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
LICENCE: CC-BY-NC
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
